Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > While we wait...

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Mar 16, 2023 11:30am

202 Views

Post# 35342547

RE:RE:RE:While we wait...

One thing that TLT has always got going for it is the fact that the study investigators are in charge of the data and, as academic clinicians, have not interest in being part of some fraud. Granted TLT has done a great job of presenting the data in very confusiong graphs and tables over time. But never misled. Bre-ex was always a fraud. TLT is safe that way. Just suffers from lots of other challenges :)

<< Previous

Bullboard Posts

Next >>

Mullen Group: Navigates market challenges towards success